Abstract: The purpose of the present invention is to provide a blood treatment material which can adsorb and remove blood components including activated leukocytes and inflammatory cytokines with high efficiency. The present invention provides a blood treatment material comprising a fibrous or particulate water-insoluble material, wherein the difference between a maximum value (RaA) and a minimum value (RaB) of the arithmetic mean roughness (Ra) of the surface of the water-insoluble material is 0.30 to 1.50 µm as calculated using a laser microscope.
| # | Name | Date |
|---|---|---|
| 1 | 202247022624.pdf | 2022-04-18 |
| 2 | 202247022624-STATEMENT OF UNDERTAKING (FORM 3) [18-04-2022(online)].pdf | 2022-04-18 |
| 3 | 202247022624-PROOF OF RIGHT [18-04-2022(online)].pdf | 2022-04-18 |
| 4 | 202247022624-PRIORITY DOCUMENTS [18-04-2022(online)].pdf | 2022-04-18 |
| 5 | 202247022624-FORM 1 [18-04-2022(online)].pdf | 2022-04-18 |
| 6 | 202247022624-DRAWINGS [18-04-2022(online)].pdf | 2022-04-18 |
| 7 | 202247022624-DECLARATION OF INVENTORSHIP (FORM 5) [18-04-2022(online)].pdf | 2022-04-18 |
| 8 | 202247022624-COMPLETE SPECIFICATION [18-04-2022(online)].pdf | 2022-04-18 |
| 9 | 202247022624-FORM-26 [12-07-2022(online)].pdf | 2022-07-12 |
| 10 | 202247022624-FORM 3 [10-08-2022(online)].pdf | 2022-08-10 |
| 11 | 202247022624-Correspondence_GPA_30-01-2023.pdf | 2023-01-30 |
| 12 | 202247022624-FORM 18 [23-06-2023(online)].pdf | 2023-06-23 |